DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Vermeire S, O’Byrne S, Keir M. et al
Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial.
Lancet 2014;
384: 309-318
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.